Print this page    •   Back to Web version of article

AIDS Trestment News
December 17, 1999

AIDS Treatment News Index, 1999

2003 | 2002 | 2001 | 2000 | 1998 | 1997 | 1996


A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z


TopicDate and Issue #Title of Article
Aaron Diamond AIDS Research Center04-Jun-99 #320Eradication or Immune Control: New Research, Issue of Focus
abacavir08-Jan-99 #310Ziagen(TM) (Abacavir) Approved: Caution Essential
Abbott05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
Abbott Laboratories01-Oct-99 #328ABT-378 Early Access Program Begins
ABT-37801-Oct-99 #328ABT-378 Early Access Program Begins
ABT-37801-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
access to care17-Dec-99 #333San Francisco General Hospital Funding Crisis: Call for Information
access to care19-Nov-99 #331Update on Tenofovir (PMPA) compassionate Access Study
access to care01-Oct-99 #328ABT-378 Early Access Program Begins
access to care16-Apr-99 #317San Francisco General Outpatient Pharmacy Problems
access to care19-Feb-99 #313Medical Marijuana: Major AIDS Organizations Seek Legal Access
access to care19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
access to care08-Jan-99 #310 1999: Treatments, Issues to Watch
access, international17-Dec-99 #333Medical Donations for Cuba
access, international19-Nov-99 #331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview with James Love
access, international05-Nov-99 #330Pharmaceutical Patents and Developing Countries
access, international03-Sep-99 #326Activists Block Gore's Office to Protest Terms of Africa Deal
access, international03-Sep-99 #326Brazil May Stop Drug Access; Problems Also Reported from Argentina
access, international03-Sep-99 #326Seattle Demonstration Preparations for Global Trade Meetings
access, international06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
access, international02-Jul-99 #322Africa, Access, and Patents: Moving Fast
access, international18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
access, international04-Jun-99 #320 Panama: Modern Antiretroviral Treatment Will Be Available
access, international21-May-99 #319Hundred Million Dollar Program for Public-Private AIDS Research and Outreach in Africa
access, international07-May-99 #318Africa and HIV/AIDS: Email Communication List
access, international16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
access, international19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
access, international05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
access, international22-Jan-99 #311A Visit to India: Drug Prices, Research, & Global Access
activism17-Dec-99 #333San Francisco General Hospital Funding Crisis: Call for Information
activism17-Dec-99 #333Medical Donations for Cuba
activism17-Dec-99 #333Northern California: One-Day Advocacy Conference, January 29
activism05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
activism05-Nov-99 #330Pharmaceutical Patents and Developing Countries
adefovir05-Nov-99 #330Adefovir: FDA Committee Votes Against Approval
adefovir15-Oct-99 #329FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3
AEGIS04-Jun-99 #320 AEGIS Nominated to UNESCO "Memory of the World"
Africa02-Jul-99 #322Africa, Access, and Patents: Moving Fast
Africa21-May-99 #319Hundred Million Dollar Program for Public-Private AIDS Research and Outreach in Africa
Africa07-May-99 #318Africa and HIV/AIDS: Email Communication List
Africa19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
African American07-May-99 #318Model AIDS Program Housed in African-American Church
African Growth and Opportunity Act19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
AGAPE Program07-May-99 #318Model AIDS Program Housed in African-American Church
Agenerase(TM)07-May-99 #318Amprenavir, New Protease Inhibitor, Approved
Agouron Pharmaceuticals07-May-99 #318Model AIDS Program Housed in African-American Church
AIDS Action20-Aug-99 #325AIDS Jobs Available
AIDS Research Alliance03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
AIDS Treatment News 08-Jan-99 #310AIDS Treatment News Financial Disclosure Update
alitretinoin19-Feb-99 #313Kaposi's Sarcoma: New Topical Treatment Approved
American Foundation for AIDS Research01-Oct-99 #328New AmFAR Treatment Directory Now Available
AmFAR01-Oct-99 #328New AmFAR Treatment Directory Now Available
Amplicor HIV Ultrasensitive Method05-Mar-99 #314Viral Load 50-Copy Test Approved
amprenavir07-May-99 #318Amprenavir, New Protease Inhibitor, Approved
anti-inflammatory21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
Antioch Baptist Church07-May-99 #318Model AIDS Program Housed in African-American Church
Argentina03-Sep-99 #326Brazil May Stop Drug Access; Problems Also Reported from Argentina
auctions19-Nov-99 #331Internet Fundraising: Online Auctions ...
Balm In Gilead, Inc.07-May-99 #318Model AIDS Program Housed in African-American Church
beginning treatment20-Aug-99 #325San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
Beier, David16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
benefits01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
benefits02-Apr-99 #316Medicare Recipients -- New Income Limits Can Increase Cash, Medical Benefits
benefits19-Feb-99 #313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to Do It)
Berlin patient12-Feb-99 #312Restoring HIV-Specific Immunity
biological approaches17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
Bombay18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
Boneberg, Paul06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
Brazil03-Sep-99 #326Brazil May Stop Drug Access; Problems Also Reported from Argentina
Bristol-Myers Squibb19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
Bristol-Myers Squibb05-Nov-99 #330ddI: FDA Approves Once-Daily Dosing
Bristol-Myers Squibb21-May-99 #319Hundred Million Dollar Program for Public-Private AIDS Research and Outreach in Africa
Bristol-Myers Squibb07-May-99 #318Model AIDS Program Housed in African-American Church
Brown & Toland07-May-99 #318Managed Care Problems: San Francisco Hearing Set for May 13
bundling02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
buyers' clubs17-Dec-99 #333Buyers' Club List, December 1999
calcium05-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
calendar20-Aug-99 #325Upcoming Research and Treatment Conferences, Meetings
California02-Jul-99 #322Medical Marijuana: California Task Force Proposes Registration System...
California02-Jul-99 #322Organ Transplants: One Million Dollars for Research
cannabinoids21-May-99 #319Medical Marijuana: AIDS- Related Information in the New Federal Report
cannabis17-Sep-99 #327Vaporizers for Medical Marijuana
capitation22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
CD8 cells15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
Cent Gardes conference05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
CHAMP17-Sep-99 #327Vaporizers for Medical Marijuana
chloroquine03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
CHORUS database19-Feb-99 #313Strategy Trials: The Answer?
Claritin18-Jun-99 #321Action Alert: Drug-Patent Bill Could Cost Patients $3 Billion+...
Cleveland07-May-99 #318Model AIDS Program Housed in African-American Church
clinical trials20-Aug-99 #325San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
clinical trials18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
clinical trials04-Jun-99 #320 HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
clinical trials04-Jun-99 #320 Treatment Interruption Research: The Trial Most Needed Now
clinical trials21-May-99 #319REMUNE Trial Will Stop; New Trials Planned
clinical trials08-Jan-99 #310Ziagen(TM) (Abacavir) Approved: Caution Essential
clinical trials, design19-Nov-99 #331FDA Clarifies Rules, Allows Combining Antiretrovirals in Clinical Trials
clinical trials, design19-Feb-99 #313Strategy Trials: The Answer?
clinical trials, design08-Jan-99 #310Improving Drug Development: Exploratory Clinical Studies
Clinton, President William16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
Coalition for Salvage Therapy05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
compounding pharmacies02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
compounding pharmacies04-Jun-99 #320 Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA Proposes Limit on Interstate Shipment
compulsory licensing16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
compulsory licensing05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
computer security16-Jul-99 #323Charges Dropped in Sex Sting; Protecting Yourself Online
conferences05-Nov-99 #330Durban Conference: February Deadlines, New Track, and Community Program
conferences05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
conferences, meetings -- lists20-Aug-99 #325Upcoming Research and Treatment Conferences, Meetings
Consumer Project on Technology16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
Consumer Project on Technology05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
copyleft03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
copyright03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
CST (Coalition for Salvage Therapy)05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
Cuba17-Dec-99 #333Medical Donations for Cuba
d4T19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
Davies Medical Center07-May-99 #318Managed Care Problems: San Francisco Hearing Set for May 13
ddI03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
ddI19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
ddI05-Nov-99 #330ddI: FDA Approves Once-Daily Dosing
developing countries see: access, international
diarrhea06-Aug-99 #324Diarrhea: New Treatment Option from Shaman
diclofenac sodium18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
dietary supplements06-Aug-99 #324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
dietary supplements18-Jun-99 #321FDA Public Meeting on Dietary Supplement Regulation...
disability01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
disability21-May-99 #319Medicaid Early Treatment Bill Now in Congress
disclosure08-Jan-99 #310AIDS Treatment News Financial Disclosure Update
DSHEA06-Aug-99 #324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
DSHEA18-Jun-99 #321FDA Public Meeting on Dietary Supplement Regulation...
Durban05-Nov-99 #330Durban Conference: February Deadlines, New Track, and Community Program
email lists03-Dec-99 #332Treatment and Related AIDS Email Lists
email lists07-May-99 #318Africa and HIV/AIDS: Email Communication List
email lists07-May-99 #318U.S. Vaccine Trial: New Email List
employment20-Aug-99 #325AIDS Jobs Available
emulgel18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
FDA19-Nov-99 #331FDA Clarifies Rules, Allows Combining Antiretrovirals in Clinical Trials
FDA19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
FDA05-Nov-99 #330Adefovir: FDA Committee Votes Against Approval
FDA05-Nov-99 #330ddI: FDA Approves Once-Daily Dosing
FDA15-Oct-99 #329FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3
FDA06-Aug-99 #324FDA Hearing Highlights Opposition to Dietary Supplement Practices...
FDA18-Jun-99 #321FDA Public Meeting on Dietary Supplement Regulation...
FDA04-Jun-99 #320 Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA Proposes Limit on Interstate Shipment
financial disclosure08-Jan-99 #310AIDS Treatment News Financial Disclosure Update
fish oil16-Apr-99 #317Fish Oil Reduced Heart Disease in Controlled Trial
foreign assistance06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
funding06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
funding08-Jan-99 #310AIDS Treatment News Financial Disclosure Update
fundraising19-Nov-99 #331Internet Fundraising: Online Auctions ...
GAAN06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
Gallo, Robert17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
Gallo, Robert19-Mar-99 #315New Antiviral Substances Found with HCG
Gates, William H07-May-99 #318Gates Foundation Donates $25 Million for AIDS Vaccines
Geigy Pharmaceuticals18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
generic drugs18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
genotypic testing02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
Getty, Jeff02-Jul-99 #322Organ Transplants: One Million Dollars for Research
Gilead Sciences19-Nov-99 #331Update on Tenofovir (PMPA) compassionate Access Study
Gilead Sciences05-Nov-99 #330Adefovir: FDA Committee Votes Against Approval
Glaxo Wellcome07-May-99 #318Amprenavir, New Protease Inhibitor, Approved
Glaxo Wellcome19-Mar-99 #315Lipodystrophy: Glaxo Researchers Suggest Mechanisms, Publish Data
Glide-Goodlett HIV/AIDS Project07-May-99 #318Model AIDS Program Housed in African-American Church
Global AIDS Action Network06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
Gore, Vice President Al03-Sep-99 #326Activists Block Gore's Office to Protest Terms of Africa Deal
Gore, Vice President Al02-Jul-99 #322Africa, Access, and Patents: Moving Fast
Gore, Vice President Al16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
Gore, Vice President Al16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
Green, Chris03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
guidelines03-Sep-99 #326Opportunistic Infections: New Treatment Guidelines Published August 20
guidelines21-May-99 #319Updated HIV Treatment Guidelines Available
HCG19-Mar-99 #315New Antiviral Substances Found with HCG
HE200004-Jun-99 #320 HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
Health Gap Coalition18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
Health Gap Coalition19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
heart disease16-Apr-99 #317Fish Oil Reduced Heart Disease in Controlled Trial
hepatitis C02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
HIV Treatment Data Project19-Feb-99 #313Strategy Trials: The Answer?
HIV-specific immunity19-Nov-99 #331Restoring HIV- Specific Immunity: Telephone Conference December 8
HIV-specific immunity12-Feb-99 #312HIV-Specific Immunity: Major Conference Sessions
HIV-specific immunity12-Feb-99 #312Restoring HIV- Specific Immunity
HIV-specific immunity08-Jan-99 #310 1999: Treatments, Issues to Watch
HMOs19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
HMOs22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
Hollis Eden04-Jun-99 #320 HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
HOPE for Africa Act19-Mar-99 #315Health Gap Coalition -- New Group for International Treatment Access
human chorionic gonadotropin19-Mar-99 #315New Antiviral Substances Found with HCG
human rights06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
hydroxychloroquine03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
hydroxyurea03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
hydroxyurea19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
hydroxyurea07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
hypersensitivity reaction08-Jan-99 #310Ziagen(TM) (Abacavir) Approved: Caution Essential
IAVI07-May-99 #318Gates Foundation Donates $25 Million for AIDS Vaccines
ICAAC01-Oct-99 #328ICAAC Conference Reports on Web
ICAAC01-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
IL-2, low dose15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
Immune Response Corporation21-May-99 #319REMUNE Trial Will Stop; New Trials Planned
immune system20-Aug-99 #325Poppers: More Evidence of Suppressed Immunity
immune system16-Apr-99 #317T-Cell Activation Predictive of Poor Survival in Advanced Disease
immune-based therapies15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
immune-based therapies02-Jul-99 #322Immune Reconstitution: New Review on Web
immune-based therapies04-Jun-99 #320 Eradication or Immune Control: New Research, Issue of Focus
immune-based therapies12-Feb-99 #312HIV-Specific Immunity: Major Conference Sessions
immune-based therapies12-Feb-99 #312Restoring HIV- Specific Immunity
India18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
India22-Jan-99 #311A Visit to India: Drug Prices, Research, & Global Access
Indonesia03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
Institute of Human Virology17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
Institute of Medicine17-Sep-99 #327Vaporizers for Medical Marijuana
Institute of Medicine21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
intellectual property03-Dec-99 #332Copyright Restrictions Block Non-English AIDS Information
International AIDS Candlelight Memorial07-May-99 #318International AIDS Candlelight Memorial and Mobilization, May 16
International AIDS Vaccine Initiative07-May-99 #318Gates Foundation Donates $25 Million for AIDS Vaccines
Internet19-Nov-99 #331Internet Fundraising: Online Auctions ...
IPAs22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
Kaiser, Jon05-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
Kaposi's sarcoma19-Feb-99 #313Kaposi's Sarcoma: New Topical Treatment Approved
Kaufman, David18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
Kuala Lumpur05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
Levin, Jules16-Jul-99 #323New York Area and Worldwide: Call-In Radio Program on HIV
Levin, Jules07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
lipodystrophy19-Mar-99 #315Lipodystrophy: Glaxo Researchers Suggest Mechanisms, Publish Data
Lisbon05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
listserves03-Dec-99 #332Treatment and Related AIDS Email Lists
listserves07-May-99 #318Africa and HIV/AIDS: Email Communication List
listserves07-May-99 #318U.S. Vaccine Trial: New Email List
Livesaving Vaccine Technology Act of 102-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
Los Angeles03-Dec-99 #332Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles
Love, James16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
Love, James05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
low-dose IL-215-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
MacDonald, Alex16-Apr-99 #317San Francisco General Outpatient Pharmacy Problems
magnesium05-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
mailing lists03-Dec-99 #332Treatment and Related AIDS Email Lists
Malaysia05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
managed care07-May-99 #318Managed Care Problems: San Francisco Hearing Set for May 13
managed care19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
managed care22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
marijuana, medical17-Sep-99 #327Vaporizers for Medical Marijuana
marijuana, medical02-Jul-99 #322Medical Marijuana: California Task Force Proposes Registration System...
marijuana, medical21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
marijuana, medical19-Feb-99 #313Medical Marijuana: Major AIDS Organizations Seek Legal Access
maternal transmission16-Jul-99 #323Major Advance in Protecting Newborns: One Nevirapine Dose Cuts Infection in Half
McCormack, Thomas P01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
McCormack, Thomas P19-Feb-99 #313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to Do It)
mechanisms17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
Medi-Cal01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
Medi-Cal21-May-99 #319Medicaid Early Treatment Bill Now in Congress
Medicaid01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
Medicaid21-May-99 #319Medicaid Early Treatment Bill Now in Congress
Medicare02-Apr-99 #316Medicare Recipients -- New Income Limits Can Increase Cash, Medical Benefits
Medicare19-Feb-99 #313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to
meetings20-Aug-99 #325Upcoming Research and Treatment Conferences, Meetings
Merigan, Thomas02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
microbicides02-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
Mirken, Bruce17-Sep-99 #327Vaporizers for Medical Marijuana
mother-infant transmission16-Jul-99 #323Major Advance in Protecting Newborns: One Nevirapine Dose Cuts Infection in Half
Mumbai18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
National Minority AIDS Council20-Aug-99 #325AIDS Jobs Available
nausea21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
neuropathy18-Jun-99 #321Neuropathy: Call for Info on Voltaren Emulgel (Topical Diclofenac Sodium)
neuropathy05-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
nevirapine16-Jul-99 #323Major Advance in Protecting Newborns: One Nevirapine Dose Cuts Infection in Half
news03-Dec-99 #332Copyright Restrictions Block Non- English AIDS Information
nitrite inhalants20-Aug-99 #325Poppers: More Evidence of Suppressed Immunity
nitrite inhalants16-Apr-99 #317Poppers: Large Cancer Increase and Immune Suppression in Animal Tests
NMAC20-Aug-99 #325AIDS Jobs Available
NORML17-Sep-99 #327Vaporizers for Medical Marijuana
Oakland Cannabis Buyers Club17-Sep-99 #327Vaporizers for Medical Marijuana
Office of National Drug Control Policy19-Feb-99 #313Medical Marijuana: Major AIDS Organizations Seek Legal Access
opportunistic infections03-Sep-99 #326Opportunistic Infections: New Treatment Guidelines Published August 20
organ transplantation02-Jul-99 #322Organ Transplants: One Million Dollars for Research
Owen, William19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
Panama04-Jun-99 #320 Panama: Modern Antiretroviral Treatment Will Be Available
pancreatitis19-Nov-99 #331ddI, d4T, Hydroxyurea; New Pancreatitis Warning
Panretin(R)19-Feb-99 #313Kaposi's Sarcoma: New Topical Treatment Approved
Paris05-Nov-99 #330Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
patents05-Nov-99 #330Pharmaceutical Patents and Developing Countries
patents03-Sep-99 #326Activists Block Gore's Office to Protest Terms of Africa Deal
patents06-Aug-99 #324International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
patents02-Jul-99 #322Africa, Access, and Patents: Moving Fast
patents02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
patents18-Jun-99 #321Action Alert: Drug-Patent Bill Could Cost Patients $3 Billion+...
patents18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
pathogenesis16-Apr-99 #317T-Cell Activation Predictive of Poor Survival in Advanced Disease
patient databases03-Sep-99 #326HIV & AIDS Treatment Registry Database: Public Registry Now Online
patient databases16-Jul-99 #323Web-Based Survey: Symptom Management for Persons Living with HIV
Pelosi, Congresswoman Nancy02-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
phenotypic testing02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
PHS guidelines03-Sep-99 #326Opportunistic Infections: New Treatment Guidelines Published August 20
PHS guidelines21-May-99 #319Updated HIV Treatment Guidelines Available
PMPA19-Nov-99 #331Update on Tenofovir (PMPA) compassionate Access Study
PMPA01-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
Podesta, John16-Apr-99 #317Clinton/Gore Top Staffs: Pharmaceutical Background
poppers20-Aug-99 #325Poppers: More Evidence of Suppressed Immunity
poppers07-May-99 #318VIAGRA: New Warning with Protease Inhibitors
poppers16-Apr-99 #317Poppers: Large Cancer Increase and Immune Suppression in Animal Tests
prices, pharmaceutical22-Jan-99 #311A Visit to India: Drug Prices, Research, & Global Access
protease inhibitors07-May-99 #318VIAGRA: New Warning with Protease Inhibitors
Public Citizen18-Jun-99 #321Action Alert: Drug-Patent Bill Could Cost Patients $3 Billion+...
public relations18-Jun-99 #321Action Alert: Drug- Patent Bill Could Cost Patients $3 Billion+...
radio16-Jul-99 #323New York Area and Worldwide: Call- In Radio Program on HIV
Rangel, Congressman Charles02-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
receptors15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
reimbursement02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
REMUNE HIV immunogen21-May-99 #319REMUNE Trial Will Stop; New Trials Planned
resistance testing15-Oct-99 #329FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3
resistance testing02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
resistance testing08-Jan-99 #310 1999: Treatments, Issues to Watch
resveratrol17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
retinoid toxicity19-Mar-99 #315Lipodystrophy: Glaxo Researchers Suggest Mechanisms, Publish Data
Retroconference 200020-Aug-99 #325Retroviruses Conferences Dates and Deadlines
retroviruses conference (1999)19-Feb-99 #313Retroviruses conference: Finding Information on the Web
Retroviruses conference (1999)12-Feb-99 #312HIV- Specific Immunity: Major Conference Sessions
Retroviruses conference (1999)12-Feb-99 #312Retroviruses Conference, Chicago 1999
Retroviruses conference (2000)20-Aug-99 #325Retroviruses Conferences Dates and Deadlines
ribavirin02-Jul-99 #322Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
RIGHT (institute)07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
Roche Diagnostics05-Mar-99 #314Viral Load 50-Copy Test Approved
salvage therapy conference18-Jun-99 #321Salvage Therapy Workshop: More Web Reports
San Francisco07-May-99 #318Managed Care Problems: San Francisco Hearing Set for May 13
San Francisco19-Feb-99 #313San Francisco: New HMO Problems threaten Access to Care
San Francisco General Hospital17-Dec-99 #333San Francisco General Hospital Funding Crisis: Call for Information
San Francisco General Hospital20-Aug-99 #325San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
San Francisco General Hospital16-Apr-99 #317San Francisco General Outpatient Pharmacy Problems
Sawyer, Eric16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
Scondras, David18-Jun-99 #321India Research Opportunities, Price and Patent Problems: Interview with David Scondras
Scondras, David04-Jun-99 #320 Treatment Interruption Research: The Trial Most Needed Now
Scondras, David22-Jan-99 #311A Visit to India: Drug Prices, Research, & Global Access
Seattle19-Nov-99 #331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview
Secure the Future21-May-99 #319Hundred Million Dollar Program for Public-Private AIDS Research and
Shaman Botanicals06-Aug-99 #324Diarrhea: New Treatment Option from Shaman
Sharp, Matt03-Sep-99 #326Treatment Advocacy Program Trains 200: Interview with Matt Sharp
Smith, Kendall15-Oct-99 #329IL-2 Low dose and Treatment Interruption: Interview with Kendall A. Smith
Social Security01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
South Africa05-Nov-99 #330Durban Conference: February Deadlines, New Track, and Community Program
South Africa02-Jul-99 #322Africa, Access, and Patents: Moving Fast
South Africa07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
South Africa16-Apr-99 #317New Frontier of AIDS Activism: International Trade Rules and Global Access
SP-30306-Aug-99 #324Diarrhea: New Treatment Option from Shaman
Spanish03-Dec-99 #332Treatment and Related AIDS Email Lists
specialist HIV care22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
SSA (Social Security Administration01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
strategy trials19-Feb-99 #313Strategy Trials: The Answer?
Strub, Sean02-Jul-99 #322Africa, Access, and Patents: Moving Fast
surveys03-Sep-99 #326HIV & AIDS Treatment Registry Database: Public Registry Now Online
surveys16-Jul-99 #323Web-Based Survey: Symptom Management for Persons Living with HIV
survival22-Jan-99 #311New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
T-2001-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
T-2016-Jul-99 #323T-20: 5-Drug Combination Trial for Heavily Treated NNRTI-Naive Patients No
T-2008-Jan-99 #310 1999: Treatments, Issues to Watch
T-cell activation16-Apr-99 #317T-Cell Activation Predictive of Poor Survival in Advanced Disease
Tat toxoid17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
TECP03-Sep-99 #326Treatment Advocacy Program Trains 200: Interview with Matt Sharp
telephone information19-Nov-99 #331Restoring HIV- Specific Immunity: Telephone Conference December 8
tenofovir19-Nov-99 #331Update on Tenofovir (PMPA) compassionate Access Study
tenofovir01-Oct-99 #328ICAAC: New Drugs in Late Breaker Session
testosterone04-Jun-99 #320 Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA Proposes Limit on Interstate Shipment
therapeutic vaccination12-Feb-99 #312Restoring HIV- Specific Immunity
treatment activism05-Nov-99 #330Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
treatment directory01-Oct-99 #328New AmFAR Treatment Directory Now Available
Treatment Education Certification Program03-Sep-99 #326Treatment Advocacy Program Trains 200: Interview with Matt Sharp
treatment interruption04-Jun-99 #320 Treatment Interruption Research: The Trial Most Needed Now
treatment interruption07-May-99 #318Interrupting HAART; Hydroxyurea; Five+ Drug Therapy -- Report from the RIGHT
treatment-naive20-Aug-99 #325San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
treatment-naive16-Jul-99 #323T-20: 5-Drug Combination Trial for Heavily Treated NNRTI-Naive Patients No
TRIPS05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
tuberculosis19-Feb-99 #313Tuberculosis Control: Many Cases Found Transmitted Despite Negative Result
UNESCO04-Jun-99 #320 AEGIS Nominated to UNESCO "Memory of the World"
vaccine17-Sep-99 #327Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
vaccine07-May-99 #318Gates Foundation Donates $25 Million for AIDS Vaccines
vaccine07-May-99 #318U.S. Vaccine Trial: New Email List
vaccine02-Apr-99 #316Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
Valentine, Fred12-Feb-99 #312Restoring HIV-Specific Immunity
vaporizers -- product information17-Sep-99 #327Vaporizers for Medical Marijuana
Vertex Pharmaceuticals07-May-99 #318Amprenavir, New Protease Inhibitor, Approved
Viagra07-May-99 #318VIAGRA: New Warning with Protease Inhibitors
viral load testing05-Mar-99 #314Viral Load 50-Copy Test Approved
viral resistance testing02-Apr-99 #316Viral Resistance Testing: Practical Issues and Future Opportunities -- Interview with Thomas Merigan, M.D.
viral resistance testing08-Jan-99 #310 1999: Treatments, Issues to Watch
vitamin B605-Mar-99 #314Neuropathy: Nutritional Prevention/Treatment Suggested
vomiting21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
Walker, Bruce D.02-Jul-99 #322Immune Reconstitution: New Review on Web
wasting syndrome21-May-99 #319Medical Marijuana: AIDS-Related Information in the New Federal Report
Women and HIV/AIDS conference15-Oct-99 #329Women and HIV/AIDS Conference: Tape, Web Reports Available
work, returning to19-Feb-99 #313Keep Your Medicare in Force As You Go Back to Work (What to Do and When to
working01-Oct-99 #328Medicaid: You Don't Always Have to Be "Disabled"
World Trade Organization19-Nov-99 #331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview with James Love
World Trade Organization03-Sep-99 #326Seattle Demonstration Preparations for Global Trade Meetings
World Trade Organization02-Jul-99 #322Africa, Access, and Patents: Moving Fast
World Trade Organization05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
WTO19-Nov-99 #331Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview with James Love
WTO03-Sep-99 #326Seattle Demonstration Preparations for Global Trade Meetings
WTO02-Jul-99 #322Africa, Access, and Patents: Moving Fast
WTO05-Mar-99 #314Compulsory Licensing for Bridging the Gap -- Treatment Access in Developing Countries: Interview with James Love, Consumer Project on Technology
XIII International AIDS Conference05-Nov-99 #330Durban Conference: February Deadlines, New Track, and Community Program
Ziagen08-Jan-99 #310ZiagenTM (Abacavir) Approved: Caution Essential





ISSN # 1052-4207

Copyright 1999 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.





This article was provided by AIDS Treatment News. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art31568.html

General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.